company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,261000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,261000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,182300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,182300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,78700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,45100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,50000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,28700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,25300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,19700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,19700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,19700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.6
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.6
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q2,2009-04-01,2009-06-30,2010-08-05 13:09:35+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.15
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,258900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,258900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,187200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,187200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,71700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-3600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,45800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,25900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,17200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,17200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,17200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.52
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.5
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2009.0,Q3,2009-07-01,2009-09-30,2010-11-05 14:01:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.52
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,274700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,274700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,192500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,192500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,82200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,46600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,53300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,28900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,25000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,19800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,19800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,19800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.6
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.6
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q1,2010-01-01,2010-03-31,2011-05-05 15:06:48+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.16
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,281800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,281800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,198600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,198600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,83200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,45800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,30500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,26700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,21700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,21700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.65
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.62
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.65
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:55:56+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.16
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,271400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,271400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,196700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,196700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,74700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,44900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-1400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,49400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,25300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,21200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,17800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,17800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,17800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.53
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.51
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.53
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q3,2010-07-01,2010-09-30,2011-11-07 10:54:13+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,276800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,276800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,198800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,198800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,78000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,50400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,14700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,72000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.18
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.18
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.18
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2010.0,Q4,2010-10-01,2010-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.17
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,295400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,295400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,207400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,207400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,88000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,50600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,28800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,24300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,19600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,19600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,19600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.59
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.56
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.59
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 16:27:57+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.17
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,307900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,307900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,223300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,223300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,84600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,46400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,56800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,27800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,23500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,20100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,20100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,20100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.6
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.6
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q2,2011-04-01,2011-06-30,2012-08-06 16:54:10+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.17
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,293600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,293600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,212200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,212200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,81400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,45700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,26100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,16900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,16900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.5
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.49
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.5
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q3,2011-07-01,2011-09-30,2012-11-05 15:32:21+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,295400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,295400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,210100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,210100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,85300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,48400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,58400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,26900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,18900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,67300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.28
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.28
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.28
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2011.0,Q4,2011-10-01,2011-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.09
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,316300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,316300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,215200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,215200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,101100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,51300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,41700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,37800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,29200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,29200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,29200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.86
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.81
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,34000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.86
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 14:42:44+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.18
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,324800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,324800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,226100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,226100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,98700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,54400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,63100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,35600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,20000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,15600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,15600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,34000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.46
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.23
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q2,2012-04-01,2012-06-30,2013-08-05 16:18:03+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.18
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,303800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,303800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,213400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,213400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,90400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,53700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,64100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,26300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,14800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,14800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,14800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.22
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,69400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.21
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.22
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 16:53:16+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,321500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,321500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,224000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,224000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,97500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,58700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-2500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,66000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,31500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,28400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,21100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,21100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.31
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.31
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.31
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2012.0,Q4,2012-10-01,2012-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.1
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,339400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,339400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,227700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,227700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,111700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,59100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,68400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,43300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,39100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,31700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,31700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.46
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,70300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.46
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 11:54:44+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.1
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,344500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,344500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,233600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,233600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,110900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,59700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,68400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,42500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,38800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,30200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,30200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,30200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.44
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,70800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.44
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q2,2013-04-01,2013-06-30,2014-08-01 16:40:34+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.1
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,341800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,341800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,236300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,236300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,105500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,56100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,65800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,39700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,35700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,26800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,26800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.38
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.37
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,70500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.38
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q3,2013-07-01,2013-09-30,2014-11-03 17:08:52+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.1
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,342700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,342700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,236100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,236100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,106600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,60000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,69700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,36900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,33500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,23600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,23600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,23600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,69600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.34
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.34
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,69800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.34
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2013.0,Q4,2013-10-01,2013-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.1
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,346800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,346800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,240400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,240400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,106400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,56400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,67100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,39300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,35700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,27100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,27100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,27100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,70600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.38
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.38
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.38
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:40:38+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.1
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,368900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,368900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,247100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,247100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,121800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,57500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,67700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,54100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,50400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,37600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,37600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,37600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,70800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.53
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.52
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,70900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.53
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q2,2014-04-01,2014-06-30,2015-08-03 17:01:36+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.1
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,355900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,355900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,246000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,246000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,109900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,56000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,65900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,44000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,41300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,31000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,31000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.44
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,70500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.44
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 17:10:52+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.11
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,349800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,349800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,240100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,240100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,109700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,58800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,65100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,44600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,41600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,31400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,31400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,70900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.44
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.44
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.44
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2014.0,Q4,2014-10-01,2014-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.11
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,335900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,335900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,226200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,226200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,109700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,55200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,61900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,47800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,44100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,32900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,32900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,32900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.46
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.46
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 15:25:12+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.11
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,359700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,359700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,241500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,241500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,118200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,60800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,10200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,79100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,39100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,36100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,27800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,27800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,27800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.39
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.38
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.39
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q2,2015-04-01,2015-06-30,2016-08-01 17:06:32+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.11
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,344500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,344500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,236200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,236200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,108300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,54600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,48700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,111800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-6600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,75000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q3,2015-07-01,2015-09-30,2016-10-31 14:19:16+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.12
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,359700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,359700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,240100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,240100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,119600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,62400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,74400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,45200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,42600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,33400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,33400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.46
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.46
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2015.0,Q4,2015-10-01,2015-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.12
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,362100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,362100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,238800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,238800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,123300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,58100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,25800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,93300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,30000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,27800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,22100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,22100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,22100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.31
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.3
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.31
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q1,2016-01-01,2016-03-31,2017-05-05 15:44:55+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.12
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,388000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,388000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,254700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,254700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,133300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,62500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,72100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,61200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,59500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,44700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,44700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,44700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.61
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.6
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.61
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 15:02:55+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.12
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,376700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,376700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,255600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,255600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,121100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,58300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,69800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,51300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,49300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,37600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,37600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,37600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.51
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.5
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.51
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q3,2016-07-01,2016-09-30,2017-10-31 16:04:04+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.13
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,382300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,382300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,258600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,258600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,123700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,60700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,71000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,52700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,53200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,16100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,39200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,39200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,39200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.53
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.51
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.53
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2016.0,Q4,2016-10-01,2016-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.13
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,387700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,387700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,253500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,253500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,134200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,62500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,73700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,60500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,59500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,3600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,60900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,60900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,60900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.83
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.81
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.83
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:58:24+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.13
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,397600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,397600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,272600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,272600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,125000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,61300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,11700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,83000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,42000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,40700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,38800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,38800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,38800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.53
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.51
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.53
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q2,2017-04-01,2017-06-30,2018-07-31 16:44:31+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.13
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,398200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,398200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,273100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,273100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,125100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,62600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-9500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,62200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,62900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,62900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,51000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,51000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,51000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.69
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.67
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.69
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 17:03:08+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.14
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,415600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,415600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,287000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,287000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,128600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,59600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,68200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,60400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,59300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,61800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2017.0,Q4,2017-10-01,2017-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.14
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,415700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,415700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,281300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,281300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,134400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,68300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,81000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,53400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,53700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,43600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,43600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,43600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.59
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.58
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.59
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:55:06+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.14
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,447500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,447500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,305300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,305300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,142200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,70000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,81900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,60300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,60100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,56100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,56100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,56100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.76
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.75
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.76
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q2,2018-04-01,2018-06-30,2019-07-29 16:48:30+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.14
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,431700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,431700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,296100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,296100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,135600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,64900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,74800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,60800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,61100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,55200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,55200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,55200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.75
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.73
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.75
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q3,2018-07-01,2018-09-30,2019-10-28 18:56:03+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.15
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,422500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,422500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,289300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,289300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,133200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,59700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-2100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,67400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,65800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,65800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,52000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,52000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,52000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.7
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.68
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.7
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2018.0,Q4,2018-10-01,2018-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.15
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,443500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,443500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,296700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,296700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,146800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,68600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-2300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,76100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,70700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,69900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,16100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,55400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,55400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,55400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.75
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.73
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.75
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q1,2019-01-01,2019-03-31,2020-04-24 16:04:57+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.15
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,469700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,469700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,311800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,311800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,157900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,70300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-2500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,77400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,80500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,79600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,66100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,66100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,66100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.9
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.88
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.9
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q2,2019-04-01,2019-06-30,2019-07-29 16:48:30+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.15
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,456100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,456100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,308300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,308300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,147800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,64800000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,6400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,80500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,67300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,64900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,2300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,56300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,56300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,56300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.76
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.75
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.76
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q3,2019-07-01,2019-09-30,2019-10-28 18:56:03+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.16
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,470600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,470600000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,317400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,317400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,153200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,69000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10200000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-4100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,75100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,78100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1300000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,100000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-700000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,77400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,16500000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,3000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,63900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,63900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,63900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74000000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.86
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75400000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.85
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73900000.0
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.86
West Pharmaceutical Services Inc,WST,5493007NKRGM1RJQ1P16,0000105770,2019.0,Q4,2019-10-01,2019-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.16
